Reference
- Goldoft MJ, Schulze TL, Parkin WE, Gunn RA. Lyme disease in New Jersey. NJ Med. 87,579–584 (1990).
- CDC. Lyme disease-United States, 2000. MMWR 51, 29–31 (2002).
- Shadick NA, Phillips CB, Logigian EL, et al. The long-term clinical outcomes of Lyme disease. A population-based retrospective cohort study. Ann. Intern. Med. 121, 560–567 (1994).
- Asch ES, Bujak DI, Weiss M, Peterson MGE, Weinstein A. Lyme disease: an infectious and postinfectious syndrome. J Rheurnatol. 21,454–456 (1994).
- Parola P, Raoult D. Ticks and tickborne bacterial diseases in humans: an emerging infectious threat. Clin. Infect. Dis. 32, 897–928 (2001).
- Wormser GP, Nadelman RB, Dattwyler RJ, et al. Practice guidelines for the treatment of Lyme disease. The Infectious Diseases Society of America. Clin. Infect. Dis. 31 (Suppl. 1), 1–14 (2000).
- Rahn DVV, Malawista SE. Lyme disease: recommendations for diagnosis and treatment. Ann. Intern. Med. 114,472–481 (1991).
- Feder HM Jr. Differences are voiced by two Lyme camps at a Connecticut public hearing on insurance coverage of Lyme disease. Pediatrics105(4 Pt 1), 855–857 (2000).
- Burrascano JJ. Lyme disease. In: Cormi Current Therapy WB Saunders Company, PA, USA 140–143 (1997).
- Kish MA. Guide to development of practice guidelines. Clin. Infect. Dis. 32, 851–854 (2001).
- Steere AC, Malawista SE, Snydman DR, Shope RE, Andiman WA, Ross MR, Steele FM. Lyme arthritis: an epidemic of oligoarticular arthritis in children and adults in three Connecticut communities. Arthritis Rheum. 20,7–17 (1977).
- Logigian EL, Kaplan RF, Steere AC. Chronic neurologic manifestations of Lyme disease. N Engl. J Med. 323,1438–1444 (1990).
- Fallon BA, Nields JA. Lyme disease: a neuropsychiatric illness. Am. J Psychiatry 151,1571–1583 (1994).
- Tylewska-Wierzbanowska S, Chmielewski T. Limitation of serological testing for Lyme borreliosis: evaluation of ELISA and western blot in comparison with PCR and culture methods. Wien Kiln Wochenschr. 114,601–605 (2002).
- Halperin JJ. Neuroborreliosis. Am. J Med. 98(4A), 52S-59S (1995).
- Battaglia HR, Alvarez G, Mercau A, Fay M, CampodOnico M. Psychiatric symptomatology associated with presumptive Lyme disease: Clinical evidence. J. Spiro Tick Dis. 7,22–25 (2000).
- Corsaro L Intramuscular Bicillin for persistent pediatric Lyme disease. Proceedings of the 9th International Conference on Lyme Borreliosis & Other Tick-borne Disorders (1999).
- Cimmino MA, Accardo S. Long-term treatment of chronic Lyme arthritis with benzathine penicillin. Ann. Rheum. Dis. 51, 1007–1008 (1992).
- Fallon BA, Tager F, Keilp J, Weiss N, Liebowitz MR, Fein L, Liegner K. Repeated antibiotic treatment in chronic Lyme disease. J Spiro Tick Dis. 6,94–102 (1999).
- Lawrence C, Lipton RB, Lowy FD, Coyle PK. Seronegative chronic relapsing neuroborreliosis. Eur. Neurol. 35,113–117 (1995).
- Cameron DJ. Monitoring Lyme disease in the community-First surveillance database sentinel health site. Proceedings of the 12th Annual International Scientific Conference on Lyme Disease and Other Spirochetal and Tick-Borne Disorders (1999).
- Fallon BA, Kochevar JM, Gaito A, Nields JA. The underdiagnosis of neuropsychiatric Lyme disease in children and adults. Psychiatr. Clin. North Am. 21,693–703 (1998).
- Klempner MS, Hu LT, Evans J, et al. Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease. N Engl. J Med. 345,85–92 (2001).
- Dinerman H, Steere AC. Lyme disease associated with fibromyalgia. Ann. Intern. Med. 117,281–285 (1992).
- Snicker RB, Lautin A. The Lyme wars: time to listen. Expert Opin. Investig. Drugs 12,1609–1614 (2003).
- Nadelman RB, Wormser GP. Erythema migrans and early Lyme disease. Am. J Med. 98(4A), S15-S24 (1995).
- Nowakowski J, McKenna D, Nadelman RB, et al. Failure of treatment with cephalexin for Lyme disease. Arch. Farn. Med. 9, 563–567 (2000).
- Steere AC, Broderick TF, Malawista SE. Erythema chronicum migrans and Lyme arthritis: epidemiologic evidence for a tick vector. Am. I Epiderniol. 108,312–321 (1978).
- Petrovic M, Vogelaers D, Van Renterghem L, Carton D, De Reuck J, Afschrift M. Lyme borreliosis-a review of the late stages and treatment of four cases. Acta Clin. Belg. 53,178–183 (1998).
- Tilton RC, Sand MN, Manak M. The Western immunoblot for Lyme disease: determination of sensitivity, specificity and interpretive criteria with use of commercially available performance panels. Clin. Infect. Dis. 25 (Suppl. 1), S31-S34 (1997).
- CDC. Recommendations for test performance and interpretation from the second national conference on serologic diagnosis of Lyme disease. MMWR 44, 590–591 (1995).
- Trevejo RT, Krause PJ, Sikand VK, Schriefer ME, Ryan R, Lepore T, Porter W, Dennis DT. Evaluation of two-test serodiagnostic method for early Lyme disease in clinical practice. J Infect. Dis. 179,931–938 (1999).
- Aguero-Rosenfeld ME, Nowakowski J, McKenna DF, Carbonaro CA, Wormser GP. Serodiagnosis in early Lyme disease. Clin. Microbiol. 31,3090–3095 (1993).
- Harris N. An understanding of laboratory testing for Lyme disease. J Spiro Tick Dis. 5,16–26 (1998).
- Ma B, Christen B, Leung D, Vigo-Pelfrey C. Serodiagnosis of Lyme borreliosis by Western immunoblot: reactivity of various significant antibodies against Borrelia burgdorferi. j Clin. Microbiol. 30,370–376 (1992).
- Engstrom SM, Shoop E, Johnson RC. Immunoblot interpretation criteria for serodiagnosis of early Lyme disease. J Microbiol. 33,419–427 (1995).
- Magnarelli LA. Laboratory analyses for Lyme disease. Conn. Med. 53,331–334 (1989).
- Krause PJ, Telford S, Spielman A, Sikand VJ, Ryan R, Christianson D, Burke G, Brassard P, Pollack R, Peck J, Persing DH. Concurrent Lyme disease and Babesiosis: Evidence for increased severity and duration of illness. JAMA 275,1657–1660 (1996).
- Luft BJ, Dattwyler RJ, Johnson RC, et al. Azithromycin compared with amoxicillin in the treatment of erythema migrans: a double-blind, randomized, controlled trial. Ann. Intern. Med. 124,785–791 (1996).
- Dattwyler RJ, Luft BJ, Kunkel M, et al. Ceftriaxone compared with doxycycline for the treatment of acute disseminated Lyme disease. N Engl. J Med. 337,289–294 (1997).
- Barsic B, Maretic T, Majerus L, Strugar J. Comparison of azithromycin and doxycycline in the treatment of erythema migrans. Infection 28,153–156 (2000).
- Scott LI, Ormrod D, Goa KL. Cefuroxime axetil: an updated review of its use in the management of bacterial infections. Drugs 61,1455–1500 (2001).
- Dattwyler RJ, Grunwaldt E, Luft BJ. Clarithromycin in treatment of early Lyme disease: a pilot study. Antirnicrob. Agents Chernother 40,468–469 (1996).
- Karlsson M, Hammers-Berggren S, Lindquist L, et al. Comparison of iv. penicillin G and oral doxycycline for treatment of Lyme neuroborreliosis. Neurology 44, 1203–1207 (1994).
- Dotevall L, Hagberg L. Successful oral doxycycline treatment of Lyme disease-associated facial palsy and meningitis. Gun. Infect. Dis. 28,569–574 (1999).
- Luft BJ, Volkman DJ, Halperin JJ, Dattwyler RJ. New chemotherapeutic approaches in the treatment of Lyme borreliosis. Ann. NY Acad. Sci. 539, 352–361 (1988).
- Battaglia HR, Alvarez G, Mercau A, Fay M, Campod6nico M. Psychiatric symptomatology associated with presumptive Lyme disease: clinical evidence. J Spiro]. Tick Di& 7,22–25 (2000).
- Ziska MH, Donta ST, Demarest FC. Physician preferences in the diagnosis and treatment of Lyme disease in the United States. Infection 24,182–186 (1996).
- Culp RW, Eichenfield AH, Davidson RS, Drummond DS, Christofersen MR, Goldsmith DP. Lyme arthritis in children. An orthopedic perspective. J Bone Joint Surg. Am. 69,96–99 (1987).
- Weiss LM. Babesiosis in humans: a treatment review. Expert Opin. Pharmacother. 3,1109–1115 (2002).
- Logigian EL, Kaplan RF, Steere AC. Successful treatment of Lyme encephalopathy with iv. ceftriaxone. Infect. Dis. 180,377–383 (1999).
- Dattwyler RJ, Halperin JJ, Volkman DJ, Luft BJ. Treatment of late Lyme borreliosis-randomized comparison of ceftriaxone and penicillin. Lancet 1191–1194 (1988).
- Schoen RT, Aversa JM, Rahn DW, Steere AC. Treatment of refractory chronic Lyme arthritis with arthroscopic synovectomy. Arthritis Rheum. 34, 1056–1060 (1991).
- Pavia CS. Current and novel therapies for Lyme disease. Expert Opin. Invest-V. Drugs 12,1003–1016 (2003).
- Krause PJ, Lepore T, Sikand VK, et al. Atovaquone and azithromycin for the treatment of babesiosis. N Engl. J Med. 343,1454–1458 (2000).
- Steere AC, Green J, Schoen RT, et al. Successful parenteral penicillin therapy of established Lyme arthritis. N Engl. J. Med. 312,869–874 (1985).
- Fallon BA. Chronic Lyme Disease Research Study. A double-blind placebo-controlled randomized clinical trial evaluating the efficacy of ten weeks of iv. ceftriaxone and effects on brain imaging. Enrollment since 2000.
- Cameron DJ. Lyme Disease Retreatment Study. A double-blind placebo-controlled randomized clinical trial evaluating the efficacy of oral amoxicillin for seropositive and seronegative Lyme disease. Enrollment since 2001.
- Eppes SC, Klein JD, Caputo G, Rose CD. Physician beliefs, attitudes and approaches toward Lyme disease in an endemic area. Clin. Pediatr. 33,130–134 (1994).
- Pena CA, Mathews AA, Siddiqi NH, Strickland GT. Antibiotic therapy for Lyme disease in a population-based cohort. CIM. Infect. Dis. 29,694–695 (1999).
- Wahlberg P, Granlund H, Nyman D, Panelius J, Seppala I. Treatment of late Lyme borreliosis. J Infect. 29,255–261 (1994).
- Donta ST. Tetracycline therapy for chronic Lyme disease. CIM. Infect. Dis. 25 (Suppl. 1), S52-S56 (1997).
- Reid MC, Schoen RT, Evans J, Rosenberg JC, Horwitz RI. The consequences of overdiagnosis and overtreatment of Lyme disease: an observational study. Ann. Intern. Med. 128,354–362 (1998).
- Steere AC, Taylor E, McHugh GL, Logigian EL. The overdiagnosis of Lyme disease. JAMA 269,1812–1816 (1993).
- Sigal LH. Anxiety and persistence of Lyme disease. Am.j Med. 98(4A), 74S-78S (1995).
Website
- Burrascano JJ Jr. Managing Lyme disease: diagnostic hints and treatment guidelines for Lyme borreliosis, 2003. Accessed at www.ILADS.org on November 1,2003.